Article
Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
18 Jan 2021
Abstract excerpt
Abstract Development of chemoresistance in breast cancer patients greatly increases mortality. Thus, understanding mechanisms underlying breast cancer resistance to chemotherapy is of paramount importance to overcome this clinical challenge. Although activated Notch receptors have been associated with chemoresistance in cancer, the specific Notch ligands and their molecular mechanisms leading to chemoresistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
